<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health Care Quality, Access, and Evaluation &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/therapeutic_category/n05/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Sun, 07 Jun 2026 04:01:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Health Care Quality, Access, and Evaluation &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Cytisine</title>
		<link>https://clinicaltrials.eu/drug/cytisine/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 05 Jun 2026 10:17:38 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/drug/cytisine/</guid>

					<description><![CDATA[Cytisine: A Promising Medication for Smoking Cessation Table of Contents What is Cytisine? How Cytisine Works Conditions Treated Dosage and Administration Effectiveness Side Effects and Safety Ongoing Research What is Cytisine? Cytisine is a medication used to help people quit smoking. It&#8217;s a plant-based substance that has been used for smoking cessation in some parts [&#8230;]]]></description>
										<content:encoded><![CDATA[<h1>Cytisine: A Promising Medication for Smoking Cessation</h1>
<h2>Table of Contents</h2>
<ul>
<li><a href="#what-is-cytisine">What is Cytisine?</a></li>
<li><a href="#how-cytisine-works">How Cytisine Works</a></li>
<li><a href="#conditions-treated">Conditions Treated</a></li>
<li><a href="#dosage-and-administration">Dosage and Administration</a></li>
<li><a href="#effectiveness">Effectiveness</a></li>
<li><a href="#side-effects-and-safety">Side Effects and Safety</a></li>
<li><a href="#ongoing-research">Ongoing Research</a></li>
</ul>
<h2 id="what-is-cytisine">What is Cytisine?</h2>
<p>Cytisine is a medication used to help people quit smoking. It&#8217;s a plant-based substance that has been used for smoking cessation in some parts of Eastern and Central Europe for over 50 years<sup><a href="#NCT02585024">[1]</a></sup>. Cytisine is also known by other names, including:</p>
<ul>
<li>Tabex</li>
<li>Desmoxan</li>
<li>Cytisinicline</li>
</ul>
<p>While it has been used in Europe for a long time, cytisine is not yet approved for use in many countries such as New Zealand, Australia, the UK, or the US<sup><a href="#NCT02585024">[1]</a></sup>.</p>
<h2 id="how-cytisine-works">How Cytisine Works</h2>
<p>Cytisine works in a similar way to other smoking cessation medications like varenicline (Champix). It acts on the brain by:</p>
<ul>
<li>Stimulating nicotine receptors, but to a lesser extent than nicotine itself</li>
<li>Blocking nicotine from binding to its receptors</li>
<li>Reducing the rewarding effects of smoking cigarettes</li>
</ul>
<p>This mechanism helps reduce cravings and withdrawal symptoms when a person stops smoking<sup><a href="#NCT02585024">[1]</a></sup>.</p>
<h2 id="conditions-treated">Conditions Treated</h2>
<p>Cytisine is primarily used for:</p>
<ul>
<li><b>Smoking Cessation</b>: Helping people quit smoking tobacco cigarettes<sup><a href="#NCT02585024">[1]</a></sup></li>
<li><b>Vaping Cessation</b>: Some studies are also looking at its effectiveness in helping people quit e-cigarettes or vaping<sup><a href="#NCT06435221">[2]</a></sup></li>
</ul>
<h2 id="dosage-and-administration">Dosage and Administration</h2>
<p>Cytisine is typically taken as oral tablets. The dosage schedule can vary, but one common regimen is<sup><a href="#NCT06579846">[3]</a></sup>:</p>
<ul>
<li>Days 1-3: 1 tablet every 2 hours (maximum 6 per day)</li>
<li>Days 4-12: 1 tablet every 2.5 hours (maximum 5 per day)</li>
<li>Days 13-16: 1 tablet every 3 hours (maximum 4 per day)</li>
<li>Days 17-20: 1 tablet every 5 hours (maximum 3 per day)</li>
<li>Days 21-25: 1-2 tablets per day</li>
</ul>
<p>This schedule is designed to gradually reduce the dose over 25 days. It&#8217;s important to follow the prescribed dosage carefully and not exceed the recommended amount.</p>
<h2 id="effectiveness">Effectiveness</h2>
<p>Studies have shown that cytisine can be effective for smoking cessation:</p>
<ul>
<li>It has been found to be more effective than placebo (a dummy pill) in helping people quit smoking</li>
<li>Some research suggests it may be more effective than nicotine replacement therapy (NRT)<sup><a href="#NCT02585024">[1]</a></sup></li>
<li>Ongoing studies are comparing its effectiveness to other smoking cessation medications like varenicline<sup><a href="#NCT04015414">[4]</a></sup></li>
</ul>
<h2 id="side-effects-and-safety">Side Effects and Safety</h2>
<p>Like all medications, cytisine can cause side effects. Researchers are conducting studies to better understand its safety profile. Some potential side effects and safety considerations include:</p>
<ul>
<li>Nausea</li>
<li>Vomiting</li>
<li>Stomach discomfort</li>
<li>Changes in heart rate or blood pressure</li>
<li>Headache</li>
<li>Sleep disturbances</li>
</ul>
<p>It&#8217;s important to discuss potential side effects with a healthcare provider before starting cytisine. They can help weigh the benefits against the risks for each individual<sup><a href="#NCT06435221">[2]</a></sup>.</p>
<h2 id="ongoing-research">Ongoing Research</h2>
<p>Several clinical trials are currently underway to further investigate cytisine. These studies aim to:</p>
<ul>
<li>Evaluate the long-term safety of cytisine when used for up to 52 weeks<sup><a href="#NCT06435221">[2]</a></sup></li>
<li>Compare the effectiveness of cytisine to other smoking cessation medications like varenicline<sup><a href="#NCT04015414">[4]</a></sup></li>
<li>Investigate the use of cytisine in combination with exercise programs for smoking cessation<sup><a href="#NCT06579846">[3]</a></sup></li>
<li>Study the effectiveness of cytisine in people who also have alcohol use disorder<sup><a href="#NCT05729243">[5]</a></sup></li>
<li>Examine how food affects the absorption and effectiveness of cytisine<sup><a href="#NCT03268343">[6]</a></sup></li>
</ul>
<p>These ongoing studies will help researchers better understand how cytisine works, its optimal dosing, and its effectiveness compared to other treatments for smoking cessation.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Human Plasma Proteins With Not Less Than 96% Albumin</title>
		<link>https://clinicaltrials.eu/drug/human-plasma-proteins-with-not-less-than-96-albumin/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 02 Jun 2026 09:59:19 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/drug/human-plasma-proteins-with-not-less-than-96-albumin/</guid>

					<description><![CDATA[Human Plasma Proteins with Not Less Than 96% Albumin: A Comprehensive Guide for Patients Table of Contents What is Albumin? Medical Uses of Albumin Albumin in Decompensated Cirrhosis Albumin in Cardiac Surgery How is Albumin Administered? Safety and Side Effects Ongoing Research What is Albumin? Human plasma proteins with not less than 96% albumin, often [&#8230;]]]></description>
										<content:encoded><![CDATA[<h1>Human Plasma Proteins with Not Less Than 96% Albumin: A Comprehensive Guide for Patients</h1>
<h2>Table of Contents</h2>
<ul>
<li><a href="#what-is-albumin">What is Albumin?</a></li>
<li><a href="#medical-uses">Medical Uses of Albumin</a></li>
<li><a href="#decompensated-cirrhosis">Albumin in Decompensated Cirrhosis</a></li>
<li><a href="#cardiac-surgery">Albumin in Cardiac Surgery</a></li>
<li><a href="#administration">How is Albumin Administered?</a></li>
<li><a href="#safety">Safety and Side Effects</a></li>
<li><a href="#ongoing-research">Ongoing Research</a></li>
</ul>
<h2 id="what-is-albumin">What is Albumin?</h2>
<p><b>Human plasma proteins with not less than 96% albumin</b>, often simply referred to as albumin, is a medication derived from human blood plasma. Albumin is the most abundant protein in human blood and plays crucial roles in maintaining health<sup><a href="#ref1">[1]</a></sup>.</p>
<p>Albumin has several important functions in the body:</p>
<ul>
<li>It helps maintain proper fluid balance in your blood vessels and tissues</li>
<li>It transports various substances throughout your body, including hormones, vitamins, and medications</li>
<li>It helps maintain blood pressure</li>
<li>It acts as an antioxidant, protecting your body from harmful substances</li>
</ul>
<h2 id="medical-uses">Medical Uses of Albumin</h2>
<p>Albumin is used to treat various medical conditions, particularly those involving low blood volume or low albumin levels in the blood. Some common uses include:</p>
<ul>
<li><b>Hypovolemia</b>: A condition where there&#8217;s not enough blood circulating in your body</li>
<li><b>Hypoalbuminemia</b>: Low levels of albumin in the blood, which can occur in various diseases</li>
<li><b>Liver disease</b>: Particularly in cases of severe cirrhosis</li>
<li><b>Burns</b>: To help replace lost fluids and proteins</li>
<li><b>Shock</b>: To help restore blood volume</li>
<li><b>Certain types of surgery</b>: To maintain proper fluid balance</li>
</ul>
<h2 id="decompensated-cirrhosis">Albumin in Decompensated Cirrhosis</h2>
<p>One area where albumin is being extensively studied is in the treatment of <b>decompensated cirrhosis</b>. This is an advanced stage of liver disease where the liver can no longer function properly<sup><a href="#ref1">[1]</a></sup>.</p>
<p>In decompensated cirrhosis, albumin is used to:</p>
<ul>
<li>Treat ascites (fluid buildup in the abdomen)</li>
<li>Prevent complications after removal of ascites fluid (paracentesis)</li>
<li>Improve overall liver and kidney function</li>
<li>Potentially reduce the risk of infections and other complications</li>
</ul>
<p>Researchers are currently investigating a new form of albumin called <b>reHA</b> (restored Human Albumin) that may be more effective in treating decompensated cirrhosis<sup><a href="#ref1">[1]</a></sup>.</p>
<h2 id="cardiac-surgery">Albumin in Cardiac Surgery</h2>
<p>Albumin also plays a role in cardiac (heart) surgery. It&#8217;s sometimes used as part of the solution that primes the heart-lung machine used during open-heart surgeries<sup><a href="#ref2">[2]</a></sup>.</p>
<p>Additionally, albumin levels can affect how certain medications, like antibiotics, work in the body. Researchers are studying how different albumin levels might impact the effectiveness of antibiotics given during cardiac surgery<sup><a href="#ref2">[2]</a></sup>.</p>
<h2 id="administration">How is Albumin Administered?</h2>
<p>Albumin is typically given as an <b>intravenous (IV) infusion</b>, which means it&#8217;s delivered directly into your bloodstream through a vein<sup><a href="#ref1">[1]</a></sup><sup><a href="#ref2">[2]</a></sup>. The dose and frequency of administration depend on your specific condition and needs.</p>
<p>For example:</p>
<ul>
<li>In cirrhosis treatment, doses might range from 20 to 80 grams, given weekly or biweekly<sup><a href="#ref1">[1]</a></sup></li>
<li>In cardiac surgery, smaller doses of about 6 grams might be used<sup><a href="#ref2">[2]</a></sup></li>
</ul>
<h2 id="safety">Safety and Side Effects</h2>
<p>Albumin is generally considered safe, as it&#8217;s a natural component of human blood. However, like all medications, it can have side effects<sup><a href="#ref1">[1]</a></sup>. These may include:</p>
<ul>
<li>Allergic reactions (rare)</li>
<li>Fever</li>
<li>Chills</li>
<li>Nausea</li>
<li>Vomiting</li>
</ul>
<p>Your doctor will carefully monitor you during and after albumin administration to ensure your safety.</p>
<h2 id="ongoing-research">Ongoing Research</h2>
<p>Researchers are continually studying albumin to better understand its effects and potential uses. Current areas of research include:</p>
<ol>
<li><b>Restored Human Albumin (reHA)</b>: This is a new form of albumin that may be more effective in treating decompensated cirrhosis. Researchers are comparing it to standard albumin solutions to see if it can improve liver function and reduce complications more effectively<sup><a href="#ref1">[1]</a></sup>.</li>
<li><b>Albumin and Antibiotic Effectiveness</b>: Studies are looking at how albumin levels in the body might affect how well certain antibiotics work, particularly in patients undergoing cardiac surgery<sup><a href="#ref2">[2]</a></sup>.</li>
<li><b>Long-term Albumin Treatment</b>: Researchers are investigating the benefits and safety of long-term albumin treatment in patients with cirrhosis<sup><a href="#ref1">[1]</a></sup>.</li>
</ol>
<p>These ongoing studies aim to improve our understanding of albumin and potentially expand its uses in medicine.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ALFENTANIL HYDROCHLORIDE</title>
		<link>https://clinicaltrials.eu/drug/alfentanil-hydrochloride/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 02 Jun 2026 09:59:01 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/drug/alfentanil-hydrochloride/</guid>

					<description><![CDATA[ALFENTANIL HYDROCHLORIDE Clinical Trials for Severe Acute Pain Table of Contents Trial overview Who can participate Treatments being compared Study phase and design Outcomes being measured What this means for patients Trial overview The available trial is an interventional study, which means the researchers give treatments and then measure the results.[1] It studies ALFENTANIL HYDROCHLORIDE [&#8230;]]]></description>
										<content:encoded><![CDATA[<h1>ALFENTANIL HYDROCHLORIDE Clinical Trials for Severe Acute Pain</h1>
<h2>Table of Contents</h2>
<ul>
<li><a href="#trial-overview">Trial overview</a></li>
<li><a href="#who-can-participate">Who can participate</a></li>
<li><a href="#treatments-being-compared">Treatments being compared</a></li>
<li><a href="#study-phase-and-design">Study phase and design</a></li>
<li><a href="#outcomes-being-measured">Outcomes being measured</a></li>
<li><a href="#what-this-means-for-patients">What this means for patients</a></li>
</ul>
<h2 id="trial-overview">Trial overview</h2>
<p>The available trial is an <b>interventional study</b>, which means the researchers give treatments and then measure the results.<sup><a href="#ref1">[1]</a></sup> It studies ALFENTANIL HYDROCHLORIDE for <b>severe pain</b> in the <b>prehospital phase</b>, meaning care given before the patient reaches the hospital.<sup><a href="#ref1">[1]</a></sup></p>
<p>This study is authorised and plans to include 242 participants.<sup><a href="#ref1">[1]</a></sup></p>
<h2 id="who-can-participate">Who can participate</h2>
<p>The trial is for <b>adults</b> with <b>severe acute pain</b> in the pre-hospital setting.<sup><a href="#ref1">[1]</a></sup> In the study summary, severe acute pain means a pain score of 6/10 or higher on a numerical scale.<sup><a href="#ref1">[1]</a></sup></p>
<p>This focus suggests the study is meant for people who need fast pain relief before they arrive at the hospital.<sup><a href="#ref1">[1]</a></sup></p>
<h2 id="treatments-being-compared">Treatments being compared</h2>
<p>The study compares ALFENTANIL HYDROCHLORIDE, listed in the trial as <b>RAPIFEN 1 mg (0.5 mg/ml)</b>, with <b>morphine</b>.<sup><a href="#ref1">[1]</a></sup> Both treatments are given as an <b>intravenous bolus</b>, which means a quick dose directly into a vein.<sup><a href="#ref1">[1]</a></sup></p>
<p>The trial uses randomisation, so participants are assigned by chance to one of the treatment groups.<sup><a href="#ref1">[1]</a></sup> This helps make the comparison fair.<sup><a href="#ref1">[1]</a></sup></p>
<h2 id="study-phase-and-design">Study phase and design</h2>
<p>This is a <b>Phase 3</b> trial.<sup><a href="#ref1">[1]</a></sup> Phase 3 studies usually test a treatment in a larger group of people to see how well it works in real-world care.<sup><a href="#ref1">[1]</a></sup></p>
<p>The brief summary says the goal is to compare the analgesic effect, which means the ability to reduce pain, 15 minutes after the first injection.<sup><a href="#ref1">[1]</a></sup></p>
<h2 id="outcomes-being-measured">Outcomes being measured</h2>
<p>The <b>primary outcome</b> is the proportion of patients whose pain becomes 3/10 or lower 15 minutes after treatment.<sup><a href="#ref1">[1]</a></sup> This is important because it measures both speed and strength of pain relief.<sup><a href="#ref1">[1]</a></sup></p>
<p>Using a numerical pain scale helps researchers compare how much pain is left after treatment.<sup><a href="#ref1">[1]</a></sup> A lower score means less pain.<sup><a href="#ref1">[1]</a></sup></p>
<h2 id="what-this-means-for-patients">What this means for patients</h2>
<p>For patients with sudden severe pain, this trial is trying to find out whether ALFENTANIL HYDROCHLORIDE or morphine gives faster relief in the pre-hospital setting.<sup><a href="#ref1">[1]</a></sup> The study may help guide emergency pain treatment choices for adults who need quick care.<sup><a href="#ref1">[1]</a></sup></p>
<p>Because the trial measures pain only 15 minutes after the first dose, it is focused on very rapid pain control rather than long-term treatment.<sup><a href="#ref1">[1]</a></sup></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Assistance Publique Hopitaux De Paris</title>
		<link>https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 02 Jun 2026 09:57:42 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Region Midtjylland</title>
		<link>https://clinicaltrials.eu/site/region-midtjylland-3/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 02 Jun 2026 04:03:36 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/region-midtjylland-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Zealand University Hospital</title>
		<link>https://clinicaltrials.eu/site/zealand-university-hospital-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 30 May 2026 04:02:45 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/zealand-university-hospital-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Centre Hospitalier Universitaire de la Guadeloupe</title>
		<link>https://clinicaltrials.eu/site/centre-hospitalier-universitaire-de-la-guadeloupe/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 30 May 2026 04:01:55 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/centre-hospitalier-universitaire-de-la-guadeloupe/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>CHU De Martinique</title>
		<link>https://clinicaltrials.eu/site/chu-de-martinique/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 30 May 2026 04:01:54 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/chu-de-martinique/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Assistance Publique Hopitaux De Paris</title>
		<link>https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 29 May 2026 04:00:53 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Hospital Paul Brousse</title>
		<link>https://clinicaltrials.eu/site/hospital-paul-brousse/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 29 May 2026 04:00:51 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/hospital-paul-brousse/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Region Sjaelland</title>
		<link>https://clinicaltrials.eu/site/region-sjaelland/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 29 May 2026 04:00:50 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/region-sjaelland/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Region Syddanmark</title>
		<link>https://clinicaltrials.eu/site/region-syddanmark-4/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 27 May 2026 09:46:20 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/region-syddanmark-4/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Fondazione I.R.C.C.S. Istituto Neurologico Besta</title>
		<link>https://clinicaltrials.eu/site/fondazione-i-r-c-c-s-istituto-neurologico-besta/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:16:11 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/fondazione-i-r-c-c-s-istituto-neurologico-besta/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ziekenhuis Nij Smellinghe</title>
		<link>https://clinicaltrials.eu/site/ziekenhuis-nij-smellinghe/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:15:24 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/ziekenhuis-nij-smellinghe-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Azienda Socio Sanitaria Territoriale Ovest Milanese</title>
		<link>https://clinicaltrials.eu/site/azienda-socio-sanitaria-territoriale-ovest-milanese/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:15:12 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/azienda-socio-sanitaria-territoriale-ovest-milanese-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Central Finland Hospital District Central Finland Hospital Nova</title>
		<link>https://clinicaltrials.eu/site/central-finland-hospital-district-central-finland-hospital-nova/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:14:37 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/central-finland-hospital-district-central-finland-hospital-nova-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Centre Hospitalier De Cayenne</title>
		<link>https://clinicaltrials.eu/site/centre-hospitalier-de-cayenne/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:14:18 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/centre-hospitalier-de-cayenne-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Roskilde University</title>
		<link>https://clinicaltrials.eu/site/roskilde-university/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:13:12 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/roskilde-university-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Raymond-Poincare Hospital</title>
		<link>https://clinicaltrials.eu/site/raymond-poincare-hospital/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:13:06 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/raymond-poincare-hospital-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Hillerod Hospital</title>
		<link>https://clinicaltrials.eu/site/hillerod-hospital/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:13:00 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/hillerod-hospital-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Hopital Beaujon</title>
		<link>https://clinicaltrials.eu/site/hopital-beaujon/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:58 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/hopital-beaujon-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Hvidovre Hospital</title>
		<link>https://clinicaltrials.eu/site/hvidovre-hospital/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:57 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/hvidovre-hospital-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Stichting Martini Ziekenhuis</title>
		<link>https://clinicaltrials.eu/site/stichting-martini-ziekenhuis/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:52 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/stichting-martini-ziekenhuis-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Universitair Medisch Centrum Groningen</title>
		<link>https://clinicaltrials.eu/site/universitair-medisch-centrum-groningen-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:48 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/universitair-medisch-centrum-groningen-2-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Oncopole Claudius Regaud</title>
		<link>https://clinicaltrials.eu/site/oncopole-claudius-regaud/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:33 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/oncopole-claudius-regaud-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Centre Hospitalier Universitaire De Poitiers</title>
		<link>https://clinicaltrials.eu/site/centre-hospitalier-universitaire-de-poitiers/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:32 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/centre-hospitalier-universitaire-de-poitiers-5/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Danderyds Sjukhus AB</title>
		<link>https://clinicaltrials.eu/site/danderyds-sjukhus-ab/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:31 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/danderyds-sjukhus-ab-4/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Istituto Europeo Di Oncologia S.r.l.</title>
		<link>https://clinicaltrials.eu/site/istituto-europeo-di-oncologia-s-r-l/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:29 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/istituto-europeo-di-oncologia-s-r-l-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pohjois-Savon hyvinvointialue</title>
		<link>https://clinicaltrials.eu/site/pohjois-savon-hyvinvointialue/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:16 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/pohjois-savon-hyvinvointialue-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pirkanmaan hyvinvointialue</title>
		<link>https://clinicaltrials.eu/site/pirkanmaan-hyvinvointialue/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:16 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/pirkanmaan-hyvinvointialue-4/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sygehus Soenderjylland Soenderborg</title>
		<link>https://clinicaltrials.eu/site/sygehus-soenderjylland-soenderborg-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:15 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/sygehus-soenderjylland-soenderborg-2-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Rigshospitalet</title>
		<link>https://clinicaltrials.eu/site/rigshospitalet-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:12:14 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/rigshospitalet-2-3/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Rigshospitalet</title>
		<link>https://clinicaltrials.eu/site/rigshospitalet/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:11:50 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/rigshospitalet-9/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ziekenhuis Oost Limburg</title>
		<link>https://clinicaltrials.eu/site/ziekenhuis-oost-limburg/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:11:45 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/ziekenhuis-oost-limburg-5/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>University Hospital Maastricht</title>
		<link>https://clinicaltrials.eu/site/university-hospital-maastricht-2/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:11:33 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/university-hospital-maastricht-2-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Region Midtjylland</title>
		<link>https://clinicaltrials.eu/site/region-midtjylland-5/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:11:26 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/region-midtjylland-5-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Region Midtjylland</title>
		<link>https://clinicaltrials.eu/site/region-midtjylland-4/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:10:57 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/region-midtjylland-4-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Assistance Publique Hopitaux De Paris</title>
		<link>https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris-7/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:10:51 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/assistance-publique-hopitaux-de-paris-7-2/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Aalborg University Hospital</title>
		<link>https://clinicaltrials.eu/site/aalborg-university-hospital/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:10:33 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/aalborg-university-hospital-12/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Hospital Clinico San Carlos</title>
		<link>https://clinicaltrials.eu/site/hospital-clinico-san-carlos/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 12 May 2026 06:10:27 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/site/hospital-clinico-san-carlos-5/</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
